Shares of Conmed (CNMD) have risen 3% in the past four weeks, closing at $43.97. Analysts predict a potential 25.5% upside with a mean estimate of $55.2, indicating strong optimism for the stock’s future performance.

Analysts’ price targets for CNMD vary, with estimates ranging from $47.00 to $65.00. A low standard deviation of $6.65 suggests consensus among analysts. While price targets are influential, they should not be the sole basis for investment decisions.

Analysts’ price targets can be influenced by business relationships, leading to inflated estimates. However, a tight clustering of targets indicates agreement on the stock’s potential movement. Investors should approach price targets with caution and conduct further research.

While price targets may not guarantee stock gains, strong agreement among analysts on earnings estimates revisions for CNMD suggests positive future performance. The Zacks Consensus Estimate for the company has increased by 0.5% in the past month.

CNMD currently holds a Zacks Rank #2 (Buy) and has a strong track record, indicating potential upside. While consensus price targets may not be definitive, they provide guidance on the stock’s direction. Investors should consider various factors before making investment decisions.

Read more at Yahoo Finance: Read This Before Placing a Bet